Bedford, MA-based bionics company BiOM announced in December 2014 that it had recently raised $6 million from Dutch and US venture firms, bringing its total funding to $48 million, according to the Boston Business Journal (BBJ).
The company’s founder and chief technology officer is bionic limb innovator Hugh Herr, PhD, who directs the MIT Media Lab’s Biomechatronics Group in Boston. Herr is a double below-knee amputee and rock climber who wears prostheses of his lab’s design.
These are sold through his company as the BiOM T2, an ankle-foot prosthetic device that uses both passive and actively powered components to emulate biological function throughout the stance phase of the gait cycle.
The BiOM T2 is currently the company’s only product, but BBJ reported that a second device, a powered orthosis for poststroke patients with toe paralysis, is in clinical trials at the US Army’s Center for the Intrepid in San Antonio, TX.